Coding, modifier, and regulatory effects shape circulating APOL1 levels
Human Molecular Genetics · 2026
DOI: 10.1093/hmg/ddag087 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Human Molecular Genetics, 2026. Verfasst von Walt E Adamson und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biodiversity, One Health, and Veterinary Medicine, University of Glasgow, Glasgow, G12 8QQ, UK. Hauptthemen laut MEDLINE: Apolipoprotein L1, Black People, Renal Insufficiency, Chronic. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, H3Africa.
Abstract (Originalsprache)
APOL1 variants G1 and G2 are major genetic risk factors for chronic kidney disease in people with recent sub-Saharan African ancestry, yet the mechanisms linking genotype to disease remain poorly defined. Circulating APOL1 is likely to play a critical role, although how specific genotypes and regulatory variants influence circulating APOL1 levels is incompletely understood. We analysed Olink-measured APOL1 NPX (Normalized Protein eXpression) levels from 43 587 UK Biobank participants. Associations between APOL1 NPX and known genotypes were assessed in individuals with recent sub-Saharan African ancestry, including analyses of G1, G2, E150K (rs2239785) and N264K (rs73885316). We also investigated protein quantitative trait loci and cis-acting variants across the APOL1 locus, including predicted microRNA binding sites. Results indicated that APOL1 NPX varied in an APOL1 genotype-dependent manner. E150K, G1, and G2 demonstrate a clear dose-dependent relationship with APOL1 NPX, with the largest effect for G2. After accounting for APOL1 genotype, APOL1 NPX remained higher in individuals with self-reported Black or Black British ethnicity, consistent with additional regulatory elements. Multiple cis-regulatory variants near APOL1 were independently associated with APOL1 NPX, and are likely to contribute to ancestry-related differences. Together these findings demonstrate that APOL1 genotype is a major determinant of APOL1 NPX, and that G1 and G2 have distinct biological effects. Regulatory variation adds another layer of control over APOL1 NPX and may help explain population differences. These findings provide a biological framework for understanding genotype-specific molecular effects of APOL1 variation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biodiversity, One Health, and Veterinary Medicine, University of Glasgow, Glasgow, G12 8QQ, UK.
- Centre for Genomic Research, University of Liverpool, Crown Street, Liverpool, L69 7ZB.
- Women's College Hospital, Hospital for Sick Children and University of Toronto, Toronto, M5S 1B2, Canada.
ORCID-Profile: Walt E Adamson
Förderung
- Wellcome Trust
- Medical Research Council
- H3Africa
Zitieren
APA
Adamson, W. E., Noyes, H., Ogunsola, J., Parekh, R. S., Cooper, A., & MacLeod, A. (2026). Coding, modifier, and regulatory effects shape circulating APOL1 levels. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddag087
Vancouver
Adamson WE, Noyes H, Ogunsola J, Parekh RS, Cooper A, MacLeod A. Coding, modifier, and regulatory effects shape circulating APOL1 levels. Human Molecular Genetics. 2026. doi:10.1093/hmg/ddag087
BibTeX
@article{Adamson2026,
author = {Adamson, Walt E and Noyes, Harry and Ogunsola, John and Parekh, Rulan S and Cooper, Anneli and MacLeod, Annette},
title = {Coding, modifier, and regulatory effects shape circulating APOL1 levels},
journal = {Human Molecular Genetics},
year = {2026},
doi = {10.1093/hmg/ddag087}
}
EUVIMED